A Polyamine-Capturing Cyclodextrin Hydrogel for Periodontitis Treatment
By S. Wang, W. Kang, D. Wang, X. Liu, J. Feng, T. Wang, W. Zhao, J. Li, S. Ge
Originally at journals.sagepub.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
A novel cyclodextrin hydrogel that sequesters excess polyamines shows promise as a non-antibiotic adjunct for periodontitis, potentially reducing inflammation and pocket depths while limiting collateral damage to the oral microbiome.
Key points
- Targets polyamine-driven inflammation in periodontitis, a pathway not addressed by current scaling/root-planing or systemic antibiotics.
- Hydrogel is placed subgingivally after debridement; early data show measurable pocket-depth reductions at 3–6 months.
- Published in JDR (July 2026) — first peer-reviewed human evidence for this mechanism in periodontal therapy.
- If scaled, could shift practice protocols toward microbiome-sparing, locally delivered anti-inflammatory agents.
Who should care
Read the original on Journal of Dental Research (JDR)
Full reporting and any paywall content live on journals.sagepub.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Florida dental office remains closed amid patient death investigation
- ·Clinical
Association of toothbrushing, dental flossing, and interdental brushing with stroke risk
- ·Clinical
Clinical accuracy and short-term outcomes of intraoral photogrammetry for complete-arch implant rehabilitation: A retrospective multicentre study on 35 patients
- ·Clinical
Site‐Resolved Gingival Microcirculation and Colour Features in Health and Early Inflammation